Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery

NCT01841359 is registered in ClinicalTrials.gov with Joslin Diabetes Center as lead sponsor.

NCT NCT01841359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01841359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery
Lead sponsor
Joslin Diabetes Center
Phase
Phase 4
Overall status
Completed
Start date
February 2, 2010
Completion date
February 8, 2022
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

evidence of previous gastric surgery, hypoglycemia